Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
6 hedge funds and large institutions have $223K invested in Genetic Technologies Ltd. in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
36% less capital invested
Capital invested by funds: $351K → $223K (-$128K)
54% less funds holding
Funds holding: 13 → 6 (-7)
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$17.8K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$167 |
| 3 |
RCAG
Rehmann Capital Advisory Group
Lansing,
Michigan
|
+$78 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$27K |
| 2 |
AGU
Alpine Group USVI
St. Thomas,
U.S. Virgin Islands
|
-$17K |
| 3 |
VF
Virtu Financial
New York
|
-$16K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$10K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $214K | +$17.8K | +1,599 | +8% |
|
2
UBS Group
Zurich,
Switzerland
| $7K | -$6.38K | -574 | -45% |
|
|
CG
3
Cutler Group
San Francisco,
California
| $2K | – | – | – |
|
|
RCAG
4
Rehmann Capital Advisory Group
Lansing,
Michigan
| $70 | +$78 | +7 | New |
|
|
RE
5
RBC Europe
London,
United Kingdom
| $38 | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$27K | -2,258 | Closed |
|
|
AGU
7
Alpine Group USVI
St. Thomas,
U.S. Virgin Islands
| – | -$17K | -1,422 | Closed |
|
|
VF
8
Virtu Financial
New York
| – | -$16K | -1,354 | Closed |
|
|
OMC
9
Old Mission Capital
Chicago,
Illinois
| – | -$10K | -851 | Closed |
|
|
10
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$10K | -850 | Closed |
|
11
Jane Street
New York
| – | -$6K | -502 | Closed |
|
|
ASN
12
Advisory Services Network
Atlanta,
Georgia
| – | +$167 | +15 | +300% |
|
GENE Hedge Fund Activity: Q3 2019 in Review
6 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2019, worth a combined $223K — down 36% from $351K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GENE and 1 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $17.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $27K sold.
- 6 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2019, down from 13 in Q2 2019.
- Funds reported $223K of Genetic Technologies Ltd. stock for Q3 2019, down 36% quarter-over-quarter.
- 1 fund opened new Genetic Technologies Ltd. positions in Q3 2019 and 8 closed out, a net change of -7 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2019 was Renaissance Technologies, an estimated $17.8K added.
- The largest Genetic Technologies Ltd. seller in Q3 2019 was Citadel Advisors, an estimated $27K sold.
Based on aggregated 13F filings for Q3 2019.